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Abstract
West Nile virus (WNV) is a neurovirulent mosquito-borne flavivirus, which main natural hosts are birds but it also infects
equines and humans, among other mammals. As in the case of other plus-stranded RNA viruses, WNV replication is
associated to intracellular membrane rearrangements. Based on results obtained with a variety of viruses, different cellular
processes have been shown to play important roles on these membrane rearrangements for efficient viral replication.
As these processes are related to lipid metabolism, fatty acid synthesis, as well as generation of a specific lipid
microenvironment enriched in phosphatidylinositol-4-phosphate (PI4P), has been associated to it in other viral models. In
this study, intracellular membrane rearrangements following infection with a highly neurovirulent strain of WNV were
addressed by means of electron and confocal microscopy. Infection of WNV, and specifically viral RNA replication, were
dependent on fatty acid synthesis, as revealed by the inhibitory effect of cerulenin and C75, two pharmacological inhibitors
of fatty acid synthase, a key enzyme of this process. However, WNV infection did not induce redistribution of PI4P lipids, and
PI4P did not localize at viral replication complex. Even more, WNV multiplication was not inhibited by the use of the
phosphatidylinositol-4-kinase inhibitor PIK93, while infection by the enterovirus Coxsackievirus B5 was reduced. Similar
features were found when infection by other flavivirus, the Usutu virus (USUV), was analyzed. These features of WNV
replication could help to design specific antiviral approaches against WNV and other related flaviviruses.
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Introduction
West Nile virus (WNV) is a mosquito-borne pathogen
responsible for outbreaks of febrile illness, meningitis, encephalitis,
and flaccid paralysis. Its main natural hosts are birds, although
equines and humans, among other mammals, can also be infected
[1]. WNV has been associated with sporadic outbreaks of
meningoencephalitis in Africa, Europe, and the Middle East [2].
Since 1999, when the virus emerged for the first time in the USA
[3,4], WNV has spread across the American continent, being
responsible of over 30,000 diagnosed infections, more than 12,000
cases of meningitis/encephalitis, and over 1,100 human fatalities
[1,2]. Likewise, since then, over 25,000 accumulated cases in
horses have been reported only in the USA [1]. Lately, an increase
in the frequency and severity of WNV outbreaks involving equines
and humans in Europe and the Mediterranean basin has also been
observed [5].
WNV is a plus-strand RNA virus classified within the Flaviviridae
family inside the genus Flavivirus together with other important
human pathogens as Dengue virus (DENV), St. Louis encepha-
litis virus, Yellow Fever virus, or tick-borne encephalitis virus.
The Flaviviridae family also includes another important human
pathogen, the hepatitis C virus, HCV, (Hepacivirus genus). As a
general feature, cells infected by plus-strand RNA viruses undergo
notable intracellular membrane remodelling [6,7,8,9]. For Kunjin
virus (KUNV), the Australian variant of WNV, major membrane
reorganizations leading to different well defined structures aimed
to establish the viral replication complex have been described
[6,10,11,12]. The primary membrane source for these structures is
provided by the endoplasmic reticulum (ER), although the
presence of markers from organelles involved in the endocytic
pathway (endosomes/lysosomes) or from the Golgi complex
remains unclear [10,11,13].
Membrane rearrangements driven by viral infections promote
efficient viral replication by achieving the optimal lipid and protein
conditions for anchoring viral replication machinery [7]. These
phenomena lead to the formation of organelle-like structures
specific for virus replication [9,14]. Regarding lipid composition of
these organelle-like structures, a requirement of fatty acid synthesis
and the involvement of the key enzyme of this pathway, the fatty
acid synthase (FASN), has been documented for enteroviruses
(such as poliovirus, PV, and Coxsackievirus B3, CVB3) and
members of the Flavivridae family [15,16,17,18,19], thus making of
FASN a promising antiviral target. Based on results obtained with
CVB3, PV and HCV, it has been also recently proposed that a
common specific lipid microenvironment enriched in phosphati-
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viruses [14]. In the case of HCV, this microenvironment was
shown to be produced by specific recruitment of the phosphati-
dylinositol-4-kinase IIIa (PI4KIIIa) and also PI4KIIIb to the viral
replication complex [20,21,22,23,24]. According to these findings,
a number of studies have shown that replication of enteroviruses
and HCV is inhibited by the drug PIK93 [14,24,25], which
specifically blocks the PI4KIIIb [26] and also interferes with
PI4KIIIa [24]. In addition, apart from providing an adequate
platform for viral replication, intracellular membrane rearrange-
ments can also favour viral infection by contributing to evade the
cellular immune response [27]. In the case of WNV, these
membrane rearrangements could play a role for the evasion of
innate immune response by interfering with the interferon
signalling machinery [28,29].
Understanding the mechanisms involved in replication complex
organization is of crucial interest for the design of novel antiviral
approaches. Thus, in the present report we have analyzed the
implication of cellular cofactors in membrane rearrangements
induced by the highly neurovirulent strain of WNV responsible for
the encephalitis outbreak that took place in NY in 1999. These
cellular requirements were also investigated for the Usutu virus
(USUV), an emerging flavivirus in Europe responsible for recent
cases of neuroinvasive disease in humans [30,31].
Methods
Cells, viruses, infections, and virus titration
All manipulations of infectious virus were carried out in
Biosafety level 3 (BSL-3) containment facilities. WNV strain
NY99 [4], USUV strain SAAR 1776 [32] and CVB5 strain
Faulkner [33] were propagated in Vero cells [34]. Vero cells were
used in all experiments, except those involving FASN detection,
which were performed in Huh-7 cells [35] because commercial
antibody tested worked better on this cell line. Procedures for
infections have been previously described [34,36]. Viral titer was
determined 24 h postinfection (p.i.) for WNV or USUV and 8 h
p.i. for CVB5 by plaque assay. Ten-fold serial dilutions of viral
samples were carried out in duplicate and adsorbed to Vero cells
grown on six-well tissue culture dishes. After removal of the
inoculum, infection was allowed to continue in semi-solid medium
containing 1% low-melting-point agarose (Pronadisa, Madrid,
Spain) and 2% fetal bovine serum. Infected plates were fixed with
4% formaldehyde at 3 days p.i. Semisolid medium was removed
and plaques were visualized by staining with 0.3% crystal violet in
2% formaldehyde plus 10% ethanol.
Antibodies, stainings and reagents
Double-stranded RNA (dsRNA) and WNV envelope (E) protein
were detected using mouse monoclonal antibodies J2 (English &
Scientific Consulting Bt., Hungary) and 3.67G (Millipore,
Temecula, CA), respectively. Calreticulin and LAMP-1 were
detected using Rabbit polyclonal antibodies from Abcam (Cam-
bridge, UK). Rabbit polyclonal antibodies against calnexin and
mouse monoclonal antibody against GM130 were from ECM
Biosciences (Versailles, KY). Rabbit polyclonal antibody against
FASN, and mouse monoclonal anti-a-tubulin B512 were from
Sigma (St. Louis, MO). Wheat germ agglutinin (WGA) coupled to
Alexa Fluor (AF)-594, To-Pro-3 and secondary antibodies against
mouse or Rabbit IgGs coupled to AF-488, -594 or -647 were
purchased from Invitrogen (Molecular Probes, Eugene, O). Anti-
rabbit and anti-mouse secondary antibodies coupled to horserad-
ish peroxidase were from Dako (Stockholm, Sweden) and Sigma,
respectively. PIK93 was from Symansis (Washdyke, New Zeland)
and cerulenin and C75 from Sigma. Drugs were dissolved in
DMSO before use. Cell viability upon drugs treatments was
determined by ATP measurement with CellTiter-GloH lumines-
cent cell viability assay (Promega, Madison, WI).
Plasmids and transfections
The following plasmids were used in this study: plasmid
IgLdR1kdel encoding an ER targeted mRFP1 [37], plasmids
encoding wt forms of Rab4, 5, 7 or 11 fused to GFP [38,39] and a
plasmid encoding GFP-tagged FAPP1-PH [40]. All plasmids were
amplified in Escherichia coli DH5a, purified using PureLink
TM
HiPure FP Maxiprep Kit (Invitrogen, Carlsbad, CA) and
transfected using FuGENEH HD (Roche, Manheim, Germany)
as described by the manufacturer. Cells were infected 24 h post-
transfection.
Electron microscopy
Vero cells grown on 75 cm
2 tissue culture flasks were infected
with WNV or USUV (MOI of 5 PFU/cell) and 24 h p.i. were
washed and fixed 30 min at 37uC in 4% paraformaldehyde-2%
glutaraldehyde in 0.1 M phosphate buffer pH 7.4 plus 5 mM
CaCl2. Cells were scrapped and postfixed in 1% osmium
tetroxide-1% potassium ferricyanide for 1 h at 4uC, washed three
times with bidistilled water and treated with 0.15% tanic acid
(1 min). Cells were washed with the buffer and with bidistilled
water prior to the staining with 2% uranyl acetate (1 h). After
three washes with bidistilled water samples were dehydrated in
ethanol and embedded in the resin. Samples were examined using
a Jeol JEM-1010 electron microscope (Jeol, Japan) operated at
80 kV and images were acquired using a digital camera 4 K64K
TemCam-F416 (Tietz Video and Image Processing Systems
GmbH, Gauting, Germany).
Immunofluorescence and confocal microscopy
Following 24 h of infection, cells grown on glass coverslips
(Menzel-Glaser, Braunschweig, Germany) were washed twice with
phosphate buffer saline (PBS) and fixed in 4% paraformaldehyde
in PBS for 15 min at room temperature (RT). Samples were
washed twice in PBS and blocked, and permeabilized in BPTG
(1% bovine serum albumin [BSA], 0.1% Triton-X 100, 1 M
glycine in PBS) for 15 min at room temperature (RT). Then, cells
were incubated (1 h at RT) with primary antibodies diluted in 1%
BSA in PBS. After two additional washes with PBS, cells were
incubated (30 min at RT) with fluorescently labelled secondary
antibodies or WGA coupled to AF594. Nuclei were stained using
To-Pro-3 as described by the manufacturer. Samples were washed
again with PBS and mounted in Fluoromount-G
TM (Southern
Biotech, Birmingham, AL). Cells were observed using a Leica
TCS SPE confocal laser scanning microscope using an HCX PL
APO 636/1.4 oil immersion objective. Images were acquired
using Leica Advanced Fluorescence Software and processed with
ImageJ (http://rsbweb.nih.gov/ij/) and Adobe Photoshop CS2
(Adobe Inc, San Jose, CA). Optical slice thickness for all confocal
images displayed was of 1 airy unit.
Quantitative RT-PCR
Infected cultures were subjected to two freeze and thaw cycles
and viral RNA was extracted with NucleoSpin viral RNA isolation
kit (Macherey-Nagel, Du ¨ren, Germany) at 24 h p.i. from samples
treated with the drugs from 3 h p.i.. The amount of viral RNA
copies was determined by quantitative RT-PCR [41] as genomic
equivalents to PFU/ml by comparison with RNA extracted from
previously titrated samples [42,43].
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Cells were lysed on ice in RIPA buffer (150 mM NaCl, 5 mM b-
mercaptoethanol, 1% NP-40, 0.1% sodium dodecyl sulfate [SDS],
50 mM Tris-HCl pH 8) supplemented with cOmplete protease
inhibitor cocktail tablets (Roche) and protein concentration was
determined by Bradford assay. Equal amounts of proteins were
mixed with Laemmli sample buffer, subjected to SDS-PAGE and
proteins were electrotransferred onto a nitrocellulose membrane.
Membrane was blocked with 5% skimmed milk in PBS 0.05%
Tween-20, incubated with primary antibodies (over night at 4uC),
washed three times with the same buffer, and subsequently incubated
with secondary antibodies coupled to horseradish peroxidase (1 h at
RT) diluted in 1% skimmed milk in PBS-Tween. Membrane was
washed three times and proteins were detected by chemiluminiscence
using a ChemiDoc
TM XRS+ System (Bio-Rad, Hercules, CA).
Data analysis
Analysis of the variance (ANOVA) was performed with the
statistical package SPSS 15 (SPSS Inc., Chicago, IL) applying
Bonferroni’s correction for multiple comparisons. Data are
presented as means 6 standard deviations. Asterisks (*) in the
figures denote statistically significant differences (P,0.05).
Results
Intracellular membrane rearrangements involved in WNV
replication complex assembly
When intracellular membrane rearrangements in WNV-NY99
infected cells (24 h p.i.) were analyzed by transmission electron
microscopy, convoluted membranes (CM) and vesicle packets (VP)
were observed (Figure 1A panels a and b). These VPs contained
electron dense virions (Vi) and spherical vesicles (Ve), someof which
presented electron dense fibrous material inside (Figure 1A, panel b
asterisks). In some cases, association of these vesicles to the external
membrane of VP was observed (Figure 1A, panel b arrows).
ElectrondensevirionslocatedatthetipofthecisternaeinsideGolgi-
like structures were also observed (Figure 1A, panel c). The
localization of viral particles at the Golgi complex was supported by
colocalization of the structural envelope (E) protein of the virions
with this organelle (Figure S1). In addition to these membrane
rearrangements, whorls of stacked ribosome free membranes were
also observed in infected cells (Figure 1A, panel d).
By means of immunofluorescence and confocal microscopy, cell
structures were visualized using either specific antibodies against
cellular markers (calnexin and calreticulin for ER, and LAMP-1
Figure 1. Analysis of cellular components involved in WNV replication complex. (A) Ultrastructure of WNV-induced membrane alterations.
Cells infected with WNV (MOI of 5 PFU/cell) were fixed and processed for electron microscopy at 24 h p.i. (a) Electron micrograph showing membrane
alteration on WNV infected cells: convoluted membranes (CM), WNV induced-vesicles (Ve), vesicle packets (VP), and electron dense virions (Vi). (b)
Higher magnification images of VP induced by WNV infection. Black arrows indicate the point of contact between a vesicle and the outer membrane
of the VP. Asterisks denote Ve with electron dense fibrous material. (c) WNV virions trafficking through the Golgi complex. (d) Whorls of stacked
membranes. Scale bars: 200 nm. (B) Cells infected or not (mock) as in (A) were fixed and processed for immunofluorescence and confocal microscopy.
WNV dsRNA was detected using a monoclonal antibody and cellular structures were labelled by using specific antibodies, or by transfection with
plasmids encoding fluorescent fusion proteins (see text for details). Suitable secondary antibodies coupled to AF488 or 594 were used. Scale bar:
10 mm.
doi:10.1371/journal.pone.0024970.g001
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the Golgi complex, or by performing transfections with plasmids
encoding fluorescent proteins markers for different cellular
compartments (IgLdR1kdel for ER, and Rab 4, 5, 7, and 11 for
endosomes) (Figure 1B). Signal from double-stranded RNA
(dsRNA), a marker of the viral replication complex, was observed
as cytoplasmic foci in infected cells, but not in mock-infected cells.
However, WNV dsRNA only colocalized with markers from the
ER (calnexin, calreticulin and IgLdR1kdel), and excluded the
WGA marker from Golgi complex, as well as markers from early,
recycling and late endosomes (Rab 4, 5, 7 and 11) or lysosomes
(LAMP-1).
WNV replication requires fatty acid synthesis
As WNV replication induced notable intracellular membrane
rearrangements, the involvement of different cellular lipids on
WNV replication was analyzed. The role of fatty acid synthesis in
WNV replication was analyzed by using two pharmacological
inhibitors of FASN: cerulenin and C75 [44]. Both cerulenin and
C75 reduced WNV production when added to the culture medium
either at 0 h or 3 h p.i. (Figure 2A), thus showing that these drugs
affected viral replication stages rather than entry steps. Working
concentrations of these inhibitors had no major effects on cell
viability (Figure S2), indicating that the inhibition of viral
production could be attributed to the inhibition of the targeted
cellular process. Viral replication in the presenceof FASN inhibitors
was further investigated analyzing viral RNA synthesis by means of
quantitative RT-PCR (Figure 2B). These experiments confirmed
that inhibition of WNV production by cerulenin and C75 when
added 3 h p.i. was derived from a reduction in the synthesis of viral
RNA. Then, the location of FASN in WNV-infected cells was
analyzed by inmunofluorescence microscopy (Figure 2C). Mock-
infected cells displayed a diffuse cytoplasmic staining of FASN,
whereas localization of FASN close to WNV replication complexes
was observed in infected cells at 12 or 24 h p.i. Analysis by western
blot revealed that no significant changes in the relative levels of
FASN were observed during WNV infection (Figure 2D).
WNV replication is independent of PI4P
The role of PI4P lipids, which have been shown to play an
important role in RNA virus replication (see Introduction), was
analyzed on WNV replication. As shown in Figure 3A, in mock-
infected cells transfected with a plasmid encoding a GFP-tagged
FAPP1-PH protein, which binds to PI4P lipids, PI4P localized at
discrete structures surrounding cell nuclei, colocalizing with Golgi
markers WGA and GM130, and thus indicating a primary
distribution of this lipid at the Golgi complex. Likewise, confocal
laser scanning microscopy of cells transfected with PI4P reporter
plasmid and later infected with WNV did not show redistribution
of PI4P, and colocalization of PI4P with WGA close to the nucleus
was observed, thus indicating that PI4P was also located at the
Golgi complex in WNV infected cells (Figure 3B). Even more, no
colocalization of PI4P with dsRNA was observed (Figure 3B upper
panels), since when calreticulin was used as a marker for the ER it
was noted that dsRNA was located at the ER and excluded PI4P
lipids (Figure 3B lower panels). On the other hand, enterovirus
CVB5-infected cells showed a redistribution of PI4P lipids that
could be also found outside Golgi complex (Figure 3C upper
panels) and not excluding the ER (Figure 3C lower panels). In
addition to these, PI4P lipids colocalized with dsRNA, showing
that they were located to CVB5 replication complexes (Figure 3C).
Next, the effect of the inhibition of PI4P synthesis by PIK93 was
Figure 2. Replication of WNV is dependent on fatty acid synthesis. (A) WNV infection requires active fatty acid synthesis. Cells infected with
WNV (MOI of 0.5 PFU/cell) were treated with 15 mM cerulenin or 15 mM C75 from 0 or 3 h p.i. throughout the rest of the assay and total virus yield
was determined at 24 h p.i. (B) Genome replication of WNV is dependent on fatty acid synthesis. Cells were infected and treated with FASN inhibitors
from 3 h p.i. as in (A). RNA was extracted at 24 h p.i. and the number of WNV RNA copies was determined by quantitative RT-PCR. (C) Localization of
FASN in mock and WNV-infected Huh-7 cells. Infected cells (MOI of 5 PFU/cell) were fixed and processed for immunofluorescence (12 or 24 h p.i.)
using a rabbit anti-FASN antibody in combination with a monoclonal antibody against dsRNA. Primary antibodies were detected using suitable AF-
488 or 594 labelled secondary antibodies. Scale bar: 10 mm. (D) Analysis of FASN levels during WNV infection. Huh-7 cells were infected with WNV as
in (A) and lysed at different times p.i. Western blot analysis was performed to determine the relative levels of FASN protein. Membrane was retested
against a tubulin antibody as a control for protein loading.
doi:10.1371/journal.pone.0024970.g002
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quantitative RT-PCR and virus titration (24 h p.i.), no statistically
significant differences on WNV RNA synthesis (Figure 3D) and no
reduction on viral production were observed upon PIK93
treatment (Figure 3E) when the drug was added at 0 or 3 h p.i.
The capability of PIK93 to interfere on viral replication was
confirmed by the effect that it exerted on CVB5 infected cells, in
which a dose-dependent inhibition was observed when PIK93 was
added either at 0 or 3 h p.i.
Replication of USUV shares common requirements with
WNV
The findings observed for WNV replication were also
investigated using another Flavivirus of the Japanese encephalitis
serocomplex. Infection with USUV in Vero cells cursed with
cythopathic effect, and shared comparable growth kinetics to that
of WNV although USUV titers were one order of magnitude
lower (Figure 4A). Infection by both viruses induced apoptosis in
cultured cells at late infection stages, since cell nuclei displaying
Figure 3. Replication of WNV is independent of PI4P. (A) Localization of PI4P at the Golgi complex in mock-infected cells. Cells transfected with
a plasmid encoding a GFP-tagged FAPP1-PH protein to detect PI4P were fixed and processed for immunofluorescence (24 h p.i.) using WGA-AF594
and a mouse monoclonal antibody against GM130 (revealed with a secondary antibody coupled to AF647). (B) Localization of PI4P in WNV infected
cells. Cells transfected as in (A) and later infected with WNV (MOI of 5 PFU/cell) were fixed and processed for immunofluorescence (24 h p.i.). WGA
labelled with AF594 or a rabbit anti-calreticulin antibody was used in combination with a monoclonal antibody against dsRNA. Primary antibodies
were detected using suitable AF594 or 647 labelled secondary antibodies. (C) Cells transfected as in (A) and later infected with CVB5 (MOI of 5 PFU/
cell) were fixed and processed for immunofluorescence (8 h p.i.) as described in (B). (D) WNV RNA replication is independent of PI4KIIIb function. Cells
infected with WNV (MOI of 0.5 PFU/cell) were treated with different concentrations of PIK93 from 0 or 3 h p.i. throughout the rest of the assay. RNA
from infected plates was extracted at 24 h p.i. and the number of WNV RNA copies was determined by quantitative RT-PCR. (E) Cells were infected
with WNV or CVB5 and treated with PIK93 as in (D). Total virus yield (24 h p.i. for WNV and 8 h p.i. for CVB5) was determined by plaque assay. Scale
bars: 10 mm.
doi:10.1371/journal.pone.0024970.g003
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alization, were observed (Figure 4B, arrows). Cells infected with
USUV (24 h p.i.) were analyzed by transmission electron
microscopy (Figure 5A). Vesicle packets (VP) were observed
(Figure 1A panels a and b). As commented for WNV, these VPs
contained electron dense virions (Vi) and spherical vesicles (Ve),
some of which presented electron dense fibrous material inside
(Figure 1A, panels a and b asterisks). Association of these vesicles
to the external membrane of VP was also noted (Figure 1A, panels
a and b arrows). Whorls of stacked ribosome free membranes were
also observed (Figure 1A, panel c). Next, cells infected with USUV
were immunostained and analyzed by confocal microscopy. As
described for WNV, in USUV-infected cells dsRNA colocalized
with calnexin (an ER marker), but excluded WGA signal, a Golgi
marker (Figure 5B). Association of USUV dsRNA with ER was
also observed in infected cells that had been previously transfected
with IgLdR1kdel plasmid, an ER reporter (Figure 5C), confirming
that USUV replication also took place associated to ER. When
lipid requirements for USUV replication were analyzed, cells
transfected with PI4P reporter plasmid and infected with USUV
did not show association of PI4P to viral replication complex
(Figure 5D), although association of FASN to viral replication
complex was observed (Figure 5E). In addition to this, infection by
USUV was not inhibited by PIK93, whereas virus yield was
reduced when cerulenin or C75 were added to the cultures 3 h
p.i., thus confirming fatty acid requirements instead of PI4P for
USUV replication (Figure 5F).
Discussion
Recent advances indicate that Flavivirus replication complex is
constituted upon structures derived from the ER [13,45].
According to this observations, the internal ‘vesicles’ observed
inside VPs, which contain dsRNA [13,45], actually constitute
invaginations from the external membrane and contact by pores
with the cell cytoplasm [13,45]. Supporting this model, we have
observed an association of these vesicles to the external membrane
of the VP, and a fibrous material stained by uranyl acetate, which
binds to phosphate groups present in nucleic acids [45], was also
observed inside some of these structures. Assembled virions may
bud into the ER (which were also observed in VP packets together
with vesicles), and traffic across the Golgi complex for maturation,
prior to extracellular release [6,10,11]. In addition to VPs, CMs,
which may be derived from the rough ER [11], as well as whorls of
stacked ribosome free membranes similar to organized smooth ER
structures [46,47] were observed. Supporting the origin of these
membranes from ER, dsRNA only colocalized with markers from
the ER. Regarding assembly of the viral replication complex
among different members of the Flaviviridae family, HCV
replication complex also contains components of the endocytic
machinery normally associated to endosomes, i.e. Rab 4, 5 and 7
[23,48], and Rab 7L1 has been also associated with DENV
replication [16]. Our results showed that all markers of endocytic
organelles tested, Rab 4, 5, 7, 11 and LAMP-1, which included
early and late endosomes as well as lysosomes, were not associated
to dsRNA in WNV infected cells, thus indicating that endocytic
machinery components are not recruited to membranous
structures where WNV replication takes place.
Membrane rearrangements driven by viral replication are
connected with lipid metabolism [14,18,19,49]. In this way, the
specific lipid content of membranes has been related either to the
achievement of proper membrane fluidity, plasticity and topology
(helping membrane curvature) or to favouring the recruitment of
viral and cellular factors to the replication complex [14,50,51,52].
Flaviviruses manipulate host-cell machinery to create an optimal
specific lipid microenvironment for assembly of their replication
complex, where cholesterol seems to play an essential role [28,53].
In this study lipid requirements, other than cholesterol, in WNV
replication were addressed. Fatty acid synthesis was found to be
related to WNV replication, as RNA replication and virus
production were reduced by drugs targeting this process. These
findings are consistent with previous reports analyzing the
involvement of fatty acid synthesis and FASN activity on the
replication of virus of the Flaviviridae family [16,17]. In the case of
DENV, it has been documented that FASN is recruited to the viral
replication complex by specific interaction with viral protein [16].
Regarding FASN levels, they were not substantially altered by
WNV infection when analyzed by western blot, consistent with
that reported for DENV [16] and in contrast to HCV-infection,
Figure 4. Comparative analysis of WNV and USUV infection
and cytophatology in Vero cells. (A) Growth curve of WNV and
USUV. Cells were infected (MOI of 0.1 PFU/cell) and supernatant virus
yield was determined at different times p.i. (B) Cells were infected as
in (A), fixed and processed for immunofluorescence and confocal
microscopy at 48 h p.i. Monoclonal antibody against dsRNA and AF-488
labelled secondary antibodies were used to detect dsRNA. Cell nucleus
was stained with To-Pro3. Arrows point to apoptotic cell nuclei. Scale
bar: 10 mm.
doi:10.1371/journal.pone.0024970.g004
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involvement of fatty acid synthesis in viral replication seems to be a
widely used strategy for RNA virus replication, since enzymes of
the fatty acid metabolic pathway are also involved in intracellular
membrane remodelling of a variety RNA virus [49,52,54].
It has been also recently proposed that a common specific lipid
microenvironment specifically enriched in PI4P is crucial for the
replication of RNA viruses as enteroviruses (CVB3 and PV) and
HCV [14]. PI4P location to the viral replication complex is
mediated by recruitment of a lipid kinase that synthesizes this lipid,
namely PI4KIIIa for HCV and PI4KIIIb for CVB3, PV, and also
HCV [14,20,21,22,23,24,25]. Our results show that, in contrast to
what hasbeendescribed for CVB3 and HCV[14,22], and observed
in this report for CVB5, PI4P was not redistributed in WNV
infected cells. Even more, the fact that PI4P lipids did not colocalize
with dsRNA indicates that they were not located at WNV
replication complex, opposite to that observed for CVB5. In
addition to these, when PIK93, a drug that specifically blocks the
PI4KIIIb [26], although it can also inhibit PI4KIIIa [24], was used,
it was observed that concentrations of PIK93 that successfully
inhibited replication of enteroviruses and HCV [14,24,25] did not
inhibit infection with WNV, or WNV RNA synthesis. This lack of
PIK93 effect revealed an independence of PI4P for WNV and
USUV replication, in contrast to that previously suggested for
enteroviruses and HCV replication [14,24].
As it has been suggested that comparative studies using different
flaviviruses may unlock crucial mechanisms of disease pathogen-
esis [27], similar experiments were carried out using USUV.
Supporting WNV results, USUV-infected cells displayed similar
membrane rearrangements to that induced by WNV, and dsRNA
also was localized at the ER. When lipid requirements for USUV
infection were analyzed, no PI4P relocalization or colocalization
with dsRNA was observed, but USUV infection, as well as WNV
infection, was also sensitive to inhibition of fatty acid synthesis and
was not affected by PIK93.
Modulation of lipid composition, specially cholesterol, is related
to viral-induced membrane rearrangements [47]. Along this line,
fatty acid biosynthesis may also act in concert with cholesterol
synthesis to enable proper membrane rearrangements for
replication complex assembly [16,55]. In addition to this, a link
between fatty acid requirements for virus replication and the
induction of autophagy, as an alternative source of fatty acids, has
been also recently reported for DENV infection [56]. The whorls
of stacked ribosome free membranes observed in this study in
WNV and USUV infected cells resembled multi-lamellar bodies,
which have been reported to be associated with autophagy, and
whose formation is also regulated through lipid composition
[57,58]. Although authophagy has been characterized for other
members of the Flaviviridae family as DENV, HCV, and Modoc
virus [56,59,60], in the case of WNV and USUV the potential role
of autophagy in viral replication remains to be explored. However,
it has been recently reported that infection by WNV results in an
induction of the unfolded protein response [61,62], which, in other
viral models leads to the induction of autophagy [63].
Figure 5. Replication of USUV is associated to the ER, requires fatty acid synthesis and is independent of PI4P. (A) Ultrastructure of
USUV-induced membrane alterations. Vero cells infected with USUV (MOI of 5 PFU/cell) were fixed and processed for electron microscopy at 24 h p.i.
(a) and (b) Electron micrographs showing membrane alteration on USUV infected cells: induced-vesicles (Ve), vesicle packets (VP), and electron dense
virions (Vi). Black arrows indicate the point of contact between a vesicle and the outer membrane of the VP. Asterisks denote Ve with electron dense
fibrous material. (c) Whorls of stacked membranes. Scale bars: 200 nm. (B). Cells infected as in (A) were fixed and processed for immunofluorescence
using a rabbit anti-calnexin antibody combined with a monoclonal antibody against dsRNA and WGA labelled with AF594. (C) Cells transfected with
plasmid encoding an mRFP1 version coupled to an ER retention signal (IgLdR1kdel) were infected with USUV as is (A) and then fixed and processed
for immunofluorescence using a monoclonal antibody against dsRNA. (D) Cells transfected with plasmid encoding a GFP-tagged FAPP1-PH protein
(to detect PI4P) were infected with USUV as is (A) and then fixed and processed for immunofluorescence using a monoclonal antibody against dsRNA
(E) USUV-infected Huh-7 cells were stained using rabbit anti-FASN antibodies combined with a monoclonal antibody against dsRNA. Suitable
secondary antibodies coupled to AF-488, 594 or 647 were used in (B), (C), (D) and (E). (F) Vero cells infected with USUV (MOI of 0.5 PFU/cell) were
treated with 1 mM PIK93, 15 mM cerulenin, or 15 mM C75 from 3 h p.i. throughout the rest of the assay, and total virus yield (24 h p.i.) was determined
by standard titration in semisolid medium. Scale bars: 10 mm.
doi:10.1371/journal.pone.0024970.g005
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complex, organized by remodelling membranes derived from the
ER, is dependent on fatty acid synthesis but does not share some
common features described for other members of the same family
(Flaviviridae), i.e. PI4P requirements or involvement of the
endocytic machinery. Apart from providing basic information of
the cellular mechanisms involved in flaviviral replication, these
unique features of WNV and USUV replication may help in the
design of specific antiviral approaches.
Supporting Information
Figure S1 Localization of WNV E protein at the Golgi
complex. Vero cells infected with WNV (MOI of 5 PFU/cell)
were fixed and processed for immunofluorescence (24 h p.i.) using
a monoclonal antibody against E glycoprotein revealed with a
suitable AF488 coupled secondary antibody, and WGA lectin
AF594 as a Golgi marker. Scale bar: 10 mm.
(TIF)
Figure S2 Analysis of cellular viability upon drug
treatments. Cellular ATP levels were determined after 24 h of
treatment with DMSO (drug vehicle), 15 mM cerulenin, 15 mM
C75 or 1 mM PIK93. RLU, relative luciferase units.
(TIF)
Acknowledgments
We thank B. Wo ¨lk for IgLdR1kdel plasmid, J. A. Esteban for plasmids
encoding Rab proteins, T. Balla for plasmid encoding GFP-tagged FAPP1-
PH, and M. T. Rejas for her assistance with electron microscopy.
Author Contributions
Conceived and designed the experiments: MAMA JCS. Performed the
experiments: MAMA ABB NJdO EER. Analyzed the data: MAMA ABB
JCS. Wrote the paper: MAMA JCS.
References
1. Murray KO, Mertens E, Despres P (2010) West Nile virus and its emergence in
the United States of America. Vet Res 41: 67.
2. Blitvich BJ (2008) Transmission dynamics and changing epidemiology of West
Nile virus. Anim Health Res Rev 9: 71–86.
3. Anderson JF, Andreadis TG, Vossbrinck CR, Tirrell S, Wakem EM, et al.
(1999) Isolation of West Nile virus from mosquitoes, crows, and a Cooper’s hawk
in Connecticut. Science 286: 2331–2333.
4. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, et al. (1999) Origin of
the West Nile virus responsible for an outbreak of encephalitis in the
northeastern United States. Science 286: 2333–2337.
5. Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, et al. (2010)
Epidemiology of west nile in europe and in the mediterranean basin. Open
Virol J 4: 29–37.
6. Mackenzie J (2005) Wrapping things up about virus RNA replication. Traffic 6:
967–977.
7. Miller S, Krijnse-Locker J (2008) Modification of intracellular membrane
structures for virus replication. Nat Rev Microbiol 6: 363–374.
8. Salonen A, Ahola T, Kaariainen L (2005) Viral RNA replication in association
with cellular membranes. Curr Top Microbiol Immunol 285: 139–173.
9. den Boon JA, Ahlquist P (2010) Organelle-like membrane compartmentalization
of positive-strand RNA virus replication factories. Annu Rev Microbiol 64:
241–256.
10. Mackenzie JM, Westaway EG (2001) Assembly and maturation of the flavivirus
Kunjin virus appear to occur in the rough endoplasmic reticulum and along the
secretory pathway, respectively. J Virol 75: 10787–10799.
11. Mackenzie JM, Jones MK, Westaway EG (1999) Markers for trans-Golgi
membranes and the intermediate compartment localize to induced membranes
with distinct replication functions in flavivirus-infected cells. J Virol 73:
9555–9567.
12. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA (1997)
Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with
double-stranded RNA, and of NS2B with NS3, in virus-induced membrane
structures. J Virol 71: 6650–6661.
13. Gillespie LK, Hoenen A, Morgan G, Mackenzie JM (2010) The endoplasmic
reticulum provides the membrane platform for biogenesis of the flavivirus
replication complex. J Virol 84: 10438–10447.
14. Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, et al. (2010) Viral
reorganization of the secretory pathway generates distinct organelles for RNA
replication. Cell 141: 799–811.
15. Rassmann A, Henke A, Jarasch N, Lottspeich F, Saluz HP, et al. (2007) The
human fatty acid synthase: a new therapeutic target for coxsackievirus B3-
induced diseases? Antiviral Res 76: 150–158.
16. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, et al. (2010) Dengue
virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral
replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A
107: 17345–17350.
17. Yang W, Hood BL, Chadwick SL, Liu S, Watkins SC, et al. (2008) Fatty acid
synthase is up-regulated during hepatitis C virus infection and regulates hepatitis
C virus entry and production. Hepatology 48: 1396–1403.
18. Guinea R, Carrasco L (1991) Effects of fatty acids on lipid synthesis and viral
RNA replication in poliovirus-infected cells. Virology 185: 473–476.
19. Guinea R, Carrasco L (1990) Phospholipid biosynthesis and poliovirus genome
replication, two coupled phenomena. Embo J 9: 2011–2016.
20. Vaillancourt FH, Pilote L, Cartier M, Lippens J, Liuzzi M, et al. (2009)
Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA
replication. Virology 387: 5–10.
21. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. (2009) A functional
genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell
Host Microbe 5: 298–307.
22. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, et al. (2011) Recruitment
and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for
Integrity of the Membranous Replication Compartment. Cell Host Microbe 9:
32–45.
23. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, et al. (2009) Roles
for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis
C virus replication. Proc Natl Acad Sci U S A 106: 7577–7582.
24. Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, et al. (2009) Class III
phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of
hepatitis C virus replication. J Virol 83: 10058–10074.
25. Arita M, Kojima H, Nagano T, Okabe T, Wakita T, et al. (2011)
Phosphatidylinositol-4 kinase III beta is a target of enviroxime-like compounds
for anti-poliovirus activity. J Virol 85: 2364–2372.
26. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, et al.
(2006) A pharmacological map of the PI3-K family defines a role for p110alpha
in insulin signaling. Cell 125: 733–747.
27. Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A (2009) Pathogenesis of
flavivirus infections: using and abusing the host cell. Cell Host Microbe 5:
318–328.
28. Mackenzie JM, Khromykh AA, Parton RG (2007) Cholesterol manipulation by
West Nile virus perturbs the cellular immune response. Cell Host Microbe 2:
229–239.
29. Hoenen A, Liu W, Kochs G, Khromykh AA, Mackenzie JM (2007) West Nile
virus-induced cytoplasmic membrane structures provide partial protection
against the interferon-induced antiviral MxA protein. J Gen Virol 88:
3013–3017.
30. Weissenbock H, Hubalek Z, Bakonyi T, Nowotny N (2010) Zoonotic mosquito-
borne flaviviruses: worldwide presence of agents with proven pathogenicity and
potential candidates of future emerging diseases. Vet Microbiol 140: 271–280.
31. Pecorari M, Longo G, Gennari W, Grottola A, Sabbatini A, et al. (2009) First
human case of Usutu virus neuroinvasive infection, Italy, August–September
2009. Euro Surveill 14.
32. Buckley A, Dawson A, Moss SR, Hinsley SA, Bellamy PE, et al. (2003)
Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection
of birds in the UK. J Gen Virol 84: 2807–2817.
33. Jimenez-Clavero MA, Escribano-Romero E, Ley V, Spiller OB (2005) More
recent swine vesicular disease virus isolates retain binding to coxsackie-
adenovirus receptor, but have lost the ability to bind human decay-accelerating
factor (CD55). J Gen Virol 86: 1369–1377.
34. Martin-Acebes MA, Saiz JC (2011) A West Nile virus mutant with increased
resistance to acid-induced inactivation. J Gen Virol 92: 831–840.
35. Gimenez-Barcons M, Wang C, Chen M, Sanchez-Tapias JM, Saiz JC, et al.
(2005) The oncogenic potential of hepatitis C virus NS5A sequence variants is
associated with PKR regulation. J Interferon Cytokine Res 25: 152–164.
36. Vazquez-Calvo A, Saiz JC, Sobrino F, Martin-Acebes MA (2011) Inhibition of
enveloped virus infection of cultured cells by valproic Acid. J Virol 85:
1267–1274.
37. Wolk B, Buchele B, Moradpour D, Rice CM (2008) A dynamic view of hepatitis
C virus replication complexes. J Virol 82: 10519–10531.
38. Gerges NZ, Backos DS, Esteban JA (2004) Local control of AMPA receptor
trafficking at the postsynaptic terminal by a small GTPase of the Rab family.
J Biol Chem 279: 43870–43878.
Cellular Lipid Requirements for WNV Replication
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e2497039. Brown TC, Correia SS, Petrok CN, Esteban JA (2007) Functional compart-
mentalization of endosomal trafficking for the synaptic delivery of AMPA
receptors during long-term potentiation. J Neurosci 27: 13311–13315.
40. Balla A, Tuymetova G, Tsiomenko A, Varnai P, Balla T (2005) A plasma
membrane pool of phosphatidylinositol 4-phosphate is generated by phospha-
tidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol
binding protein and FAPP1. Mol Biol Cell 16: 1282–1295.
41. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, et al. (2000) Rapid
detection of west nile virus from human clinical specimens, field-collected
mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay.
J Clin Microbiol 38: 4066–4071.
42. Cordoba L, Escribano-Romero E, Garmendia A, Saiz JC (2007) Pregnancy
increases the risk of mortality in West Nile virus-infected mice. J Gen Virol 88:
476–480.
43. Blazquez AB, Saiz JC (2010) West Nile virus (WNV) transmission routes in the
murine model: intrauterine, by breastfeeding and after cannibal ingestion. Virus
Res 151: 240–243.
44. Lupu R, Menendez JA (2006) Pharmacological inhibitors of Fatty Acid Synthase
(FASN)–catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer
agents? Curr Pharm Biotechnol 7: 483–493.
45. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, et al. (2009)
Composition and three-dimensional architecture of the dengue virus replication
and assembly sites. Cell Host Microbe 5: 365–375.
46. Snapp EL, Hegde RS, Francolini M, Lombardo F, Colombo S, et al. (2003)
Formation of stacked ER cisternae by low affinity protein interactions. J Cell Biol
163: 257–269.
47. Deng Y, Almsherqi ZA, Ng MM, Kohlwein SD (2010) Do viruses subvert
cholesterol homeostasis to induce host cubic membranes? Trends Cell Biol 20:
371–379.
48. Stone M, Jia S, Heo WD, Meyer T, Konan KV (2007) Participation of rab5, an
early endosome protein, in hepatitis C virus RNA replication machinery. J Virol
81: 4551–4563.
49. Lee WM, Ahlquist P (2003) Membrane synthesis, specific lipid requirements,
and localized lipid composition changes associated with a positive-strand RNA
virus RNA replication protein. J Virol 77: 12819–12828.
50. Wang X, Diaz A, Hao L, Gancarz B, den Boon JA, et al. (2011) Intersection of
the Multivesicular Body Pathway and Lipid Homeostasis in RNA Replication by
a Positive-Strand RNA Virus. J Virol.
51. McMahon HT, Gallop JL (2005) Membrane curvature and mechanisms of
dynamic cell membrane remodelling. Nature 438: 590–596.
52. Lee WM, Ishikawa M, Ahlquist P (2001) Mutation of host delta9 fatty acid
desaturase inhibits brome mosaic virus RNA replication between template
recognition and RNA synthesis. J Virol 75: 2097–2106.
53. Rothwell C, Lebreton A, Young Ng C, Lim JY, Liu W, et al. (2009) Cholesterol
biosynthesis modulation regulates dengue viral replication. Virology 389: 8–19.
54. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, et al. (2008) Systems-level
metabolic flux profiling identifies fatty acid synthesis as a target for antiviral
therapy. Nat Biotechnol 26: 1179–1186.
55. Kapadia SB, Chisari FV (2005) Hepatitis C virus RNA replication is regulated
by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A 102:
2561–2566.
56. Heaton NS, Randall G (2010) Dengue virus-induced autophagy regulates lipid
metabolism. Cell Host Microbe 8: 422–432.
57. Hariri M, Millane G, Guimond MP, Guay G, Dennis JW, et al. (2000)
Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell 11: 255–268.
58. Lajoie P, Guay G, Dennis JW, Nabi IR (2005) The lipid composition of
autophagic vacuoles regulates expression of multilamellar bodies. J Cell Sci 118:
1991–2003.
59. McLean JE, Wudzinska A, Datan E, Quaglino D, Zakeri Z (2011) Flavivirus
NS4A-induced autophagy protects cells against death and enhances virus
replication. J Biol Chem.
60. Sir D, Chen WL, Choi J, Wakita T, Yen TS, et al. (2008) Induction of
incomplete autophagic response by hepatitis C virus via the unfolded protein
response. Hepatology 48: 1054–1061.
61. Ambrose RL, Mackenzie JM (2011) West Nile virus differentially modulates the
unfolded protein response to facilitate replication and immune evasion. J Virol
85: 2723–2732.
62. Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, et al. (2007)
West Nile virus infection activates the unfolded protein response, leading to
CHOP induction and apoptosis. J Virol 81: 10849–10860.
63. Ke PY, Chen SS Autophagy: A novel guardian of HCV against innate immune
response. Autophagy 7: 533–535.
Cellular Lipid Requirements for WNV Replication
PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24970